The impact of allocation bias on test decisions in clinical trials with multiple endpoints using multiple testing strategies
Allocation bias should be considered during the design phase of a trial to increase validity. The developed methodology is useful for selecting an appropriate RP for a clinical trial with multiple endpoints to minimize allocation bias effects.
Authors
- N Heussen (ORCID: https://orcid.org/0000-0002-6134-7206)
- R.-D Hilgers (ORCID: https://orcid.org/0000-0002-5945-1119)
- Johan Verbeeck (ORCID: https://orcid.org/0000-0002-4923-1032)
- Stefanie Schoenen
Institutions
- Sigmund Freud Privatuniversität Wien (AT)
- Hasselt University (BE)
- RWTH Aachen University (DE)
Publication Details
- Journal
- BMC Medical Research Methodology
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1186/s12874-024-02335-x
- Citations
- 3
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 2.13
Funders
- European Commission
- RWTH Aachen University
- Horizon 2020